Continuous Glucose Monitors for Healthy Adults

You can now buy a continuous glucose monitor without a prescription and watch your blood sugar all day. For a healthy person, though, the device reads a noisy, approximate signal, most of the "spikes" it flags are normal physiology, and no trial has shown that reacting to them makes an already-healthy person healthier. It is a curiosity-and-education tool with real failure modes, not a longevity instrument.

If you are curious, wear one for about two weeks as an experiment, then take it off. Use it to compare a few of your everyday meals, ignore single scary readings, and never cut fruit, legumes or whole grains because they nudge the line up. If your HbA1c is borderline, that is the one group where trials show some benefit, and it is worth doing with a clinician.

What these devices are, and what "FDA-cleared" means

A continuous glucose monitor is a coin-sized sensor worn on the arm that reads glucose in the fluid between your cells every few minutes and sends it to your phone. Built for people with diabetes, it went over the counter when the US Food and Drug Administration (FDA) cleared Dexcom's Stelo in March 2024.[1] Abbott followed with two different products: Lingo, aimed at general wellness, and Libre Rio, which is meant for adults with type 2 diabetes who do not use insulin.[2] Sensors last about two weeks and cost roughly $40–55 each, or about $89 a month on subscription (mid-2026 prices).

"Cleared" is a narrow word. It means the FDA judged Stelo equivalent to a device already on the market, not that wearing it does you any good.[3] One wellness brand, Signos, has since won clearance for its app with wording about helping users "maintain a healthy weight", which shows how far the label is being stretched.[4]

In June 2026 the FDA cleared Stelo for anyone aged two and over who does not use insulin, making it the first over-the-counter monitor marketed for children.[5]

A healthy glucose curve is busier than you think

In the largest study of adults without diabetes, 560 people with normal long-term blood sugar (HbA1c, a three-month average) and normal fasting glucose wore sensors they could not see. They spent about 87% of the day between 3.9 and 7.8 mmol/L (70–140 mg/dL). That leaves roughly three hours a day above the line, and about a quarter of an hour above 10.0 mmol/L (180 mg/dL).[6]

You will often see a rosier figure quoted: 96% of the day in range and only half an hour above it. That came from a smaller, earlier study that excluded people with obesity, enrolled younger people, and let them see and calibrate their own sensors. It is the outlier.[7]

In a smaller study at Stanford, people whose blood sugar was normal on every standard test still reached prediabetic glucose levels about 15% of the time and diabetic levels about 2% of the time.[8] A short peak after a meal is expected biology, not a warning light.

Nor does the sensor reliably find hidden trouble. Among more than 1,100 adults over 75, a monitor turned up almost nothing a standard HbA1c test had missed.[9] A small study suggests some apparently healthy people carry glucose problems that standard tests miss,[10] but that argues for a targeted check, not lifelong monitoring.

Nobody agrees how to read the trace

No one has defined a "normal" wellness trace. Eighteen specialists were each shown the same 20 deliberately difficult reports from adults without diabetes. They could not agree on who needed follow-up, and their agreement was poor even after allowing for chance. More than half would refer someone who spent as little as 2% of the day above 10.0 mmol/L (180 mg/dL), even with normal HbA1c and fasting glucose.[11]

So an app telling you "your glucose is elevated" is on soft ground, yet a 2026 update to Stelo's app added a per-meal score and AI-written summaries of what your readings mean.[12] Clinical guidance for reading a trace exists only for people with diabetes.[13]

How accurate they really are

These devices are probably best treated as pattern-viewers, not lab instruments. In head-to-head testing, the best current sensors are off by about 8–14% on average against a lab test.[14] At a true reading of 5.0 mmol/L (90 mg/dL), a typical 9% error means the sensor could be about 0.4 mmol/L (8 mg/dL) off either way. Accuracy is worse at low glucose, which is exactly where a healthy user might panic about a "dip" (this was measured in adults with type 1 diabetes).[15] Nobody has independently measured the over-the-counter versions.

Three quirks matter:

  • The number lags your blood. The delay averages about 12 minutes and stretches towards 17 when glucose is falling fast. Those figures come from a 2009 sensor, and no one has measured current hardware the same way.[16]
  • Brand changes the answer. In adults with type 2 diabetes wearing a Dexcom and an Abbott sensor at once, the two disagreed by about 0.7 mmol/L (13 mg/dL) on the two-week average, the number you would actually act on.[17] In one meal study, readings varied about three to four times more between brands than within one brand.[18] In adults without diabetes, the gap was big enough to change which meals looked best: the "best" meals picked by one sensor gave only about half the benefit when scored by the other.[19]
  • Night-time "lows" are often the mattress. In someone who feels fine, a sharp overnight drop and rebound is usually a compression low, caused by lying on the sensor, not real low blood sugar.[20] In late 2025 Abbott corrected around 3 million prescription FreeStyle Libre 3 sensors that could read falsely low, a recall the FDA rated its most serious class.[21]

Does watching your glucose help?

Not in anyone like you. A 2026 review found seven randomised trials of glucose-guided behaviour change in people without diabetes. Pooled, blood-sugar control improved in people with prediabetes, but not appreciably in people with normal blood sugar, and body weight did not change significantly.[22]

The two newest trials were small (35 and 49 people), recruited people with overweight or recent weight loss rather than healthy adults, and one, which called itself a feasibility study, declared a senior author's consulting fees from a sensor maker.[23][24] Across 25 glucose-feedback trials pooled in 2024, 44% declared a conflict of interest tied to the industry, and none enrolled healthy adults.[25] A 2026 review of the whole field found only "limited and indirect" evidence for monitoring even in prediabetes or obesity, and said it should answer a specific patient problem rather than be a default.[26]

Commercial personalised-nutrition programmes don't settle it either: they do only slightly better than ordinary healthy-eating advice, and the evidence is thin. The largest trial, from the company ZOE, randomised 347 adults to a programme combining monitor data with blood-fat and gut-bacteria testing, or to standard dietary advice. After 18 weeks, triglycerides fell by about 0.13 mmol/L more, LDL ("bad") cholesterol did not move, and most of the gain came from the most committed users.[27] No trial has isolated the glucose sensor as the part that helps.

The American Diabetes Association's 2026 standards recommend monitoring for people with diabetes, and separately suggest considering it, as part of a licensed coaching programme, for people with prediabetes. They contain no recommendation to use one for screening or wellness if your blood sugar is normal.[28]

A flatter glucose curve is a stand-in measure. No study has linked flattening it in an already-healthy adult to living longer or better. Why spikes might matter is covered, with its caveats, under Glycemic index.

How it can mislead you

  • It over-flags. Compared with finger-prick blood tests in 15 healthy adults, a sensor roughly quadrupled the time it judged them "above range" (about double after correcting for each person's baseline offset). It also scored a smoothie's glycaemic impact at 69 where the blood test said 53, though that gap was only borderline and the uncertainty was wide. The authors warned it could push people towards "unnecessary food restrictions".[29]
  • Normal physiology looks like disease. The rise before you wake, the jump during hard exercise (adrenaline releases stored glucose), the bump after a bad night: all normal, all easy to misread.
  • It can breed food anxiety. In a survey of 56 monitor users, some with diabetes and some without, 89% reported healthier changes to diet or activity, but 68% also reported fear of developing type 2 diabetes when they saw a high number. Eating-disorder symptoms tracked with distress about wearing the device.[30]
  • Marketing outruns the evidence. Popular media and sensor companies blame glucose spikes for mood, sleep, brain fog and even skin ageing, effects the medical literature does not address (both did agree on blood-vessel and inflammatory effects, and the authors stress this does not prove the popular claims wrong).[31] An independent review argues that commercial claims aimed at people without diabetes should be labelled misleading.[32]

No trial has measured these harms, so they are self-reported rather than counted. But they are no longer just the critics' worry: the FDA's own 2026 clearance advises people with a history of disordered eating to speak to a clinician before using one.[33]

Who should be careful

  • Anyone on insulin, or prone to low blood sugar. The over-the-counter devices are cleared only for people not taking insulin. Stelo's label excludes anyone with problematic low blood sugar, and it has no low-glucose alarm.
  • People on dialysis. Stelo's label warns against it.
  • Anyone with a history of disordered eating. Talk to a clinician before starting, as the FDA advises (see above).

Who might benefit, and how to run a useful two weeks

The best case is a borderline HbA1c: prediabetes is the one group where monitoring has moved anything in trials.[34] After gestational diabetes, a sensor worn without viewing the readings matched a formal glucose-tolerance test at detecting diabetes and prediabetes in the months after birth, where HbA1c missed cases. That is a one-off supervised test, though, and nothing shows the earlier detection improved anyone's outcome.[35] A family history of diabetes or unexplained symptoms on their own have no trial support. Either way, run it with a clinician, not an app.

For a curious healthy person, it can be a useful short experiment:

  • Treat it as a teacher, not a scoreboard. Two weeks, then take it off.
  • Run a few controlled comparisons. The same portion of rice versus sourdough versus cooled-then-reheated pasta tells you more than staring at every wiggle. The habits that flatten the curve, such as eating vegetables and protein before starch or walking after a meal, are under Glycemic index.
  • Ignore the isolated scary reading. Patterns over days mean something; single points rarely do.
  • Don't cut healthy whole foods because they raise the line. Fibre, fruit and legumes are among the best-supported foods for long-term health regardless of a short glucose bump.

Spend the subscription money on things that are proven: fibre, fish, resistance training, sleep and a Mediterranean-style diet. The lab markers worth tracking instead, such as HbA1c, fasting insulin and the ratio of triglycerides to HDL ("good") cholesterol, are covered under Glycemic index, Metabolic flexibility and Midlife labs.

Further reading

  • Spartano NL, Prescott B, Walker ME, et al. Defining Continuous Glucose Monitor Time in Range in a Large, Community-Based Cohort Without Diabetes. J Clin Endocrinol Metab 2025.[36]
  • Spartano NL, Prescott B, Walker ME, et al. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes. J Diabetes Sci Technol 2026.[37]
  • Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biology 2018.[38]
  • Howard R, Guo J, Hall KD. Imprecision nutrition? Different simultaneous continuous glucose monitors provide discordant meal rankings for incremental postprandial glucose in subjects without diabetes. Am J Clin Nutr 2020.[39]
  • Selvin E, Wang D, Rooney MR, et al. Within-Person and Between-Sensor Variability in Continuous Glucose Monitoring Metrics. Clin Chem 2023.[40]
  • Hanson K, Kipnes M, Tran H, et al. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. J Diabetes Sci Technol 2024.[41]
  • Bermingham KM, Linenberg I, Polidori L, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nat Med 2024.[42]
  • Liao X, et al. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. Eur J Med Res 2026.[43]
  • Dower JA, et al. Continuous Glucose Monitoring in Type 2 Diabetes and Beyond: A Review. JAMA Intern Med 2026.[44]
  • Oganesova Z, Pemberton J, Brown A. Innovative solution or cause for concern? The use of continuous glucose monitors in people not living with diabetes: A narrative review. Diabet Med 2024.[45]
  • Hutchins KM, Betts JA, Thompson D, Hengist A. Continuous glucose monitor overestimates glycemia, with the magnitude of bias varying by postprandial test and individual — a randomized crossover trial. Am J Clin Nutr 2025.[46]
  • Richardson KM, Jospe MR, Somerville J, et al. Understanding the benefits and psychological burdens of using continuous glucose monitoring for lifestyle change: A mixed-methods cross-sectional study. Obes Res Clin Pract 2025.[47]
  • Daya NR, Fang M, Wang D, et al. Glucose Abnormalities Detected by Continuous Glucose Monitoring in Very Old Adults With and Without Diabetes. Diabetes Care 2025.[48]

— § —